Compumedics' trading halt and capital raising news

Compumedics (ASX:CMP) has requested a trading halt on its securities, which is effective immediately. This pause in trading is due to a forthcoming announcement regarding a proposed capital raising. The halt will last until the start of normal trading on Thursday, 5 December 2024, or until the announcement is made, whichever happens first.

Overview and future outlook

Compumedics (ASX:CMP) has requested a trading halt in accordance with ASX Listing Rule 17.1, as it prepares to announce a proposed capital raising. This halt is a strategic move to manage the information flow and ensure a fair trading environment. The company expects to resume trading by Thursday, 5 December 2024, or sooner if the announcement is released. Compumedics, known for its neurological and sleep diagnostic systems, aims to strengthen its financial position through this capital raising, aligning with its history of innovation and industry recognition. Stakeholders are advised to await the detailed announcement to understand the implications for Compumedics' financial strategy and market operations.

Executive insights on trading halt

Compumedics Limited has requested this trading halt to ensure the market is fully informed about the proposed capital raising and to facilitate an orderly market in its securities. We anticipate resuming trading once the announcement is made.